Biogen Idec’s ALS drug Failed Final Clinical Trial


Biogen Idec’s ALS drug Failed Final Clinical Trial

As per reports, it has been recently revealed that Biogen Idec was unable to get through the last clinical trial of its ALS drug. Researchers have acknowledged the loss by saying that it was not only shocking but discouraging as well.

Dr. Robert Brown, who is an ALS researcher, was of the view that they have worked hard on the drug, but they failed a crucial test. However, this does not mean that no more research will take as the disease needs an effective treatment.

While talking about the last and final clinical trial, which could not attain success, Brown said that they had enrolled 943 people, who were suffering from amyotrophic lateral sclerosis. They were enrolled to test the efficacy of their once-promising dexpramipexole drug.

After carrying out the study, Brown said that they did not find any sort of benefit from the drug. And, then only, they decided to halt the programme. "While these results were not what we expected, we hope this data will provide a foundation for future ALS research", said Dr. Douglas Kerr, who is the director of neurodegeneration clinical research at Biogen.

The failure does not mark an end to the research, said Kerr, as they still have been working on it.


Latest News

U.S. Crude Drops Further Due to Surplus Supply
CVC and CPPIB Outbid Others for a Possible Deal to Buy Petco for $4.7 Billion
US Government All Set to Introduce a New Law for Americans “Seriously Delinquent
Reportedly Pfizer Plans to Acquire Allergan in a Deal of $150 Billion or More
In October Most States Experienced a Drop in Unemployment Rate
San Francisco Fed President John Williams sees a “Strong Case” for an Interest
Cincinnati Shoppers have More Choice of Local Black Friday Deals this Year
Sliding Crude Prices Continue Giving the U.S Oil Producers Reasons to Cut Costs
American Airlines Revamps its Much Anticipated Loyalty Reward Program
Report says, Many Retailers Recycling Black Friday Deals
Optimistic Sales Posted by Retailers Walmart, Home Depot and TJX Spark a Positiv
Interest Rate Hike a Possibility or Not in December, is Still a matter